Noro-Moseley Partners
Noro-Moseley Partners is an Atlanta-based early growth equity firm founded in 1983 that invests $5-20M in B2B technology and healthcare companies with $2-20M in revenue and 50%+ growth, primarily across the Southeast and national US markets excluding the West Coast.
- Company typePrivate
- Founded1983
- HeadquartersAtlanta, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Noro-Moseley Partners does
Noro-Moseley Partners (NMP) is an Atlanta-based early growth equity firm founded in 1983 that invests in B2B technology and healthcare companies across the United States (excluding the West Coast). The firm targets high-growth businesses with 50%+ year-over-year revenue growth, $2-20M revenue run rates, compelling unit economics, significant market disruption potential, and minimal prior funding (under $20M), deploying $5-20M per company. NMP's two sector pillars are software/SaaS/internet security/tech-enabled services (led by General Partner Alan Taetle) and healthcare IT and healthcare services (led by Managing General Partner Allen Moseley). The firm operates as a private limited partnership and has invested approximately $800M across 200+ companies since inception, with exits representing over $5B in aggregate enterprise value since 2015 and 13 exits since 2013 totaling $3.3B.
NMP earns revenue through a standard private equity structure: management fees (typically ~2%) on committed and invested capital across its fund vintages, and carried interest (typically ~20%) on profits from successful portfolio company exits. The firm closed its eighth fund (NMP VIII) in May 2019 at a hard cap of $180M, $30M oversubscribed against its $150M target. The LP base includes public and sovereign pension plans, health plans and health systems, foundations, endowments, and family offices, providing both capital and, in the healthcare segment, potential strategic partnership channels for portfolio companies. The investing team of approximately 10 professionals is led by four General Partners (Moseley, Taetle, Kamath, McClelland), supported by a Principal, Senior Associate, Vice President, and Executive-in-Residence.
Notable exits include Virtustream (acquired by Dell EMC for $1.2B in 2015), Wellcentive (acquired by Philips), Clearleap (IBM), FSLogix (Microsoft), Red Canary (Zscaler, 2025), TrendKite (Cision), Navitas Credit Corp, Contessa (Amedisys, 2021), SupplyPike (SPS Commerce, 2024), and Findhelp (TPG, 2026). The firm distributes its investment offering through direct relationships with founders and management teams, referrals from its portfolio ecosystem, and regional engagement via venture competitions such as Venture Atlanta. As a partnership, NMP is owned by its partners and is not publicly traded or affiliated with a parent entity.
Noro-Moseley Partners firmographics
Firmographics- Name
- Noro-Moseley Partners
- Legal name
- Noro-Moseley Partners
- Website
- https://noromoseley.com
- Company type
- Private
- Founded year
- 1983
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Noro-Moseley Partners is an Atlanta-based early growth equity firm founded in 1983 that invests $5-20M in B2B technology and healthcare companies with $2-20M in revenue and 50%+ growth, primarily across the Southeast and national US markets excluding the West Coast.
- Ownership category
- akta.pro rank
Noro-Moseley Partners industry classification
Industry- Product category
- Venture Capital and Growth Equity
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Multi-Sector / Generalist Growth Equity (FSANACAO)
Keywords
Where Noro-Moseley Partners is headquartered
LocationHeadquarters
- HQ city
- Atlanta
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Noro-Moseley Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Management Fees: NMP charges management fees on their assets under management as a standard private equity practice. Fund VIII closed at $180 million with typical 2% management fee structure.
- Carried Interest: The firm earns carried interest (typically 20%) on profits from successful portfolio company exits. Their exits represent over $5 billion in aggregate enterprise value since 2015, generating substantial carried interest.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Noro-Moseley Partners product offering
Product offeringCore offering
Noro-Moseley Partners is a venture capital and early-growth equity firm that invests institutional fund capital into privately held B2B technology and healthcare companies, typically leading or co-leading expansion-stage rounds. The firm raises capital from limited partners into closed-end funds, deploys that capital into portfolio companies in exchange for equity, and provides board-level support, strategic guidance, and follow-on financing to founders and management teams.
Product overview
Noro-Moseley Partners is an early growth equity investment firm, not a technology product company. The firm provides investment capital and partnership services to B2B technology and healthcare companies. As such, it does not offer a unified product platform or individual software products/modules. Its investment offering consists of capital deployment ($5-20M investments), strategic advisory, and board-level support for portfolio companies.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Over $5 billion in aggregate enterprise value generated from exits since 2015
- +3 more outcomes
Companies that use Noro-Moseley Partners
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles2 records
Noro-Moseley Partners technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Noro-Moseley Partners partnerships and signals
Strategic signalScale indicators9 records
Recent moves7 records
Expansion highlights5 records
Noro-Moseley Partners competitors and assessment
Company assessmentDirect peers
- Frontier Capital: Charlotte-based growth equity firm investing in B2B software and tech-enabled services companies with $5-30M checks. Highly comparable to NMP in stage (revenue-stage growth), check size, and sector focus, though Frontier tends to be slightly larger in AUM.
- Council Capital: Nashville-based growth equity firm exclusively focused on healthcare services and healthcare IT — directly overlapping NMP's largest vertical. Similar check sizes and growth-stage focus make it one of NMP's closest direct comparables in healthcare.
- Edison Partners: Princeton-based growth equity firm investing in technology-enabled financial and enterprise services. Comparable in stage ($5-25M checks, profitable growth companies), sector tilt, and 30+ year history as a focused growth investor.
- Heritage Group: Nashville-based growth equity firm focused exclusively on healthcare innovation and tech-enabled services. Direct overlap with NMP's healthcare IT thesis at similar check sizes and growth-stage profile.
- Primus Capital: Cleveland-based growth equity firm investing in technology and tech-enabled services. Notably, Vasant Kamath (now NMP GP) previously held senior roles at Primus, signaling deep sector overlap and team continuity between the firms.
- Hatteras Venture Partners: Durham-based venture firm focused on healthcare IT and life sciences, often co-investing with NMP. Comparable in healthcare IT focus and growth-stage orientation, though Hatteras leans earlier-stage than NMP's typical entry.
- Trinity Hunt: Dallas-based growth equity firm investing in healthcare, business services, and tech-enabled companies. Similar check sizes, growth-stage focus, and sector tilt to NMP, with comparable fund structures.
- TVC Capital: San Diego-based growth equity firm focused exclusively on B2B software and SaaS companies. Directly comparable to NMP's B2B software thesis at similar revenue thresholds and growth profiles.
- Volition Capital: Boston-based growth equity firm investing in B2B software, healthcare IT, and tech-enabled services. Comparable stage focus ($5-25M checks), sector tilt, and growth-stage orientation to NMP.
Broad incumbents
- Insight Partners: New York-based scale-up investor with much larger fund size ($20B+ AUM) but overlapping healthcare IT and B2B software focus. Represents the competitive benchmark for exit multiples and the "graduation risk" as NMP portfolio companies scale beyond NMP's check size.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks1 record
Key highlights7 records
Customer concentration
Noro-Moseley Partners social profiles
Digital presenceNoro-Moseley Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Noro-Moseley Partners leadership team
Management profileNumber of profiles
Noro-Moseley Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Noro-Moseley Partners M&A and investment
M&A and investmentM&A
Investments154 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Noro-Moseley Partners
What does Noro-Moseley Partners do?
Noro-Moseley Partners is a venture capital and early-growth equity firm that invests institutional fund capital into privately held B2B technology and healthcare companies, typically leading or co-leading expansion-stage rounds. The firm raises capital from limited partners into closed-end funds, deploys that capital into portfolio companies in exchange for equity, and provides board-level support, strategic guidance, and follow-on financing to founders and management teams.
Is Noro-Moseley Partners a public or private company?
Noro-Moseley Partners is a private company. It is classified as management employee owned and is currently operating.
When was Noro-Moseley Partners founded?
Noro-Moseley Partners was founded in 1983. It employs 1 to 10 people.
Where is Noro-Moseley Partners based?
Noro-Moseley Partners is headquartered in Atlanta, United States, in the North America region.
How does Noro-Moseley Partners make money?
Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest.
Who are Noro-Moseley Partners's main competitors?
Direct peers on record are Frontier Capital, Council Capital, Edison Partners, Heritage Group, Primus Capital, Hatteras Venture Partners, Trinity Hunt, TVC Capital and Volition Capital. Insight Partners is listed as a broad incumbent.
Does Noro-Moseley Partners have an API?
No public API is recorded for Noro-Moseley Partners.
What industry is Noro-Moseley Partners in?
Noro-Moseley Partners's product category is Venture Capital and Growth Equity. Its primary akta.pro industry code is FSANACAO, Multi-Sector / Generalist Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.